Contemporary therapies for chronic heart failure with reduced ejection fraction

Keywords: heart failure with reduced ejection fraction, optimal guideline mandated therapy

Abstract

Heart failure with reduced ejection fraction (HFrEF) is common, and without optimal guideline-mandated medical therapy, is disabling and fatal. As trials discover effective additional HFrEF therapies, it is essential that all healthcare practitioners develop competence in treating these patients optimally. This narrative review discusses the approach to the contemporary medical management of HFrEF. 

The full article is available at https://doi.org/10.36303/SAGP.2020.1.4.0026

Author Biographies

E Klug, University of the Witwatersrand

Division of Cardiology, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand and Netcare Sunninghill Hospital, South Africa

N Tsabedze, University of the Witwatersrand

Division of Cardiology, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, South Africa

Published
2020-10-08
Section
Review